Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Contrast medium use.

Charles Davidson1, Fulvio Stacul, Peter A McCullough

  • 1Northwestern Memorial Hospital, Chicago, Illinois 60611, USA. cdavidson@nmh.org

The American Journal of Cardiology
|September 5, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

10-Year Outcomes of SAPIEN 3 Transcatheter Aortic Valve Replacement or Surgery in Intermediate-Risk Patients.

Journal of the American College of Cardiology·2026
Same author

Frequency and Outcomes of Acute Hemodynamic Instability Following Transcatheter Tricuspid Valve Replacement: Insights From the CESAR-TR-Registry.

JACC. Cardiovascular interventions·2026
Same author

Safety of positive gastrointestinal contrast media. Updated guidelines by the ESUR Contrast Media Safety Committee.

European radiology·2026
Same author

Povetacicept for IgA Nephropathy and Primary Membranous Nephropathy.

Kidney international reports·2026
Same author

Corticosteroids reduce pacemaker implantation after alcohol septal ablation in oHCM patients.

Clinical research in cardiology : official journal of the German Cardiac Society·2025
Same author

Safety and evidence of CO<sub>2</sub> as a vascular contrast agent as an alternative to iodine-based contrast media in vascular procedures: a systematic review by the ESUR Contrast Medium Safety Committee.

European radiology·2025
Same journal

Real-World Effectiveness and Tolerability of Sacubitril/Valsartan in Octogenarian Patients With Heart Failure: Results From the PARACHUTER Study.

The American journal of cardiology·2026
Same journal

ECG-Guided Conduction Pathways as a Lever to Shorten Post-TAVI Hospitalization.

The American journal of cardiology·2026
Same journal

Cystatin-C versus creatinine and kidney function in heart failure with preserved ejection fraction: a SOGALDI-PEF analysis.

The American journal of cardiology·2026
Same journal

Balloon-expandable versus Self-expanding Valves in Patients with Small Aortic Annuli Undergoing Transcatheter Aortic Valve Replacement.

The American journal of cardiology·2026
Same journal

Drug-Coated Balloons versus Drug-Eluting Stents following Coronary Atherectomy in Severely Calcified Lesions: A Systematic Review and Meta-Analysis.

The American journal of cardiology·2026
Same journal

Prehospital Statin Therapy and Outcomes in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

The American journal of cardiology·2026
See all related articles

Choosing the right iodinated contrast media is crucial for preventing contrast-induced nephropathy (CIN). Low-osmolar, nonionic options are safest for patients with chronic kidney disease (CKD), especially those with diabetes.

Area of Science:

  • Radiology
  • Nephrology
  • Pharmacology

Background:

  • Contrast-induced nephropathy (CIN) is a significant risk associated with iodinated contrast media.
  • Properties of contrast media like osmolality, ionic nature, and viscosity influence nephrotoxicity.
  • Patient risk factors, including chronic kidney disease (CKD) and diabetes mellitus, exacerbate CIN risk.

Purpose of the Study:

  • To evaluate the impact of different iodinated contrast media properties on the risk of CIN.
  • To identify safer contrast media choices for patients at high risk of CIN.
  • To assess the efficacy of alternative contrast agents like gadolinium or CO2.

Main Methods:

  • Review of existing clinical trial evidence and studies.
  • Comparison of nephrotoxicity across various contrast media types (high-osmolar vs. low-osmolar, ionic vs. nonionic).

Related Experiment Videos

  • Analysis of administration routes (intra-arterial vs. intravenous) and contrast volumes.

    • Main Results:

    • Low-osmolar contrast media demonstrate reduced nephrotoxicity compared to high-osmolar media in at-risk patients receiving intra-arterial contrast.
    • Nonionic isosmolar contrast media appear to offer the lowest CIN risk, particularly for CKD patients with diabetes.
    • Higher contrast volumes generally correlate with increased CIN risk, though even small volumes can affect renal function in high-risk individuals.

    Conclusions:

    • The selection of iodinated contrast media significantly impacts CIN risk.
    • Nonionic, low-osmolar contrast media are recommended for high-risk patients, especially those with CKD and diabetes.
    • Current evidence does not support the use of gadolinium or CO2 to avoid contrast-related nephrotoxicity.